United Kingdom
News
Press Releases
Curaleaf International Launches Second Medical Cannabis Flower Product for UK Market
London 27 July 2021 – Curaleaf International (formerly EMMAC Life Sciences Group), (“Curaleaf International”), Europe’s largest vertically integrated cannabis company, is pleased to announce
Curaleaf International exports over a ton of medical cannabis flower to Israel; one of the first companies to do so under new regulatory regime
London 8 July 2021 – Curaleaf International (formerly EMMAC Life Sciences Group) (“Curaleaf International”), Europe’s largest vertically integrated cannabis company, is pleased to announce
Curaleaf International secures complete GMP certification of second EU GMP Facility in Europe
Milestone for Medalchemy in Spain; facility now fully licensed to import, cultivate, extract, manufacture and export medical cannabis flower and extracts. Accelerates export capacity
Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership
London 29th June 2021 – Curaleaf International (formerly EMMAC Life Sciences Group), Europe’s largest vertically integrated cannabis company, is pleased to announce that its
Curaleaf International launches own range of Medical Cannabis Products in Germany
11 May 2021, London. Curaleaf International (formerly EMMAC Life Sciences Group), Europe’s largest vertically integrated cannabis company, is pleased to announce that its wholly
Novel Foods CBD Products Validation from the Foods Standards Agency
27 April 2021, London. Further to the announcement on 26 April 2021 that it received validation from the European Commission and European Food Safety
